Introduction
============

There is strong evidence linking exposure to estrogenic endocrine disrupting chemicals (EDCs) with the feminization of male wildlife, the decline of some species, and potential effects on human development and fertility (Guillette et al., [@B17]; Kidd et al., [@B23]; Hotckiss et al., [@B20]; Ottinger et al., [@B44]; Desforges et al., [@B12]; Mouritsen et al., [@B42]; Harris et al., [@B18]). Estrogenic chemicals also have effects in mollusks (Hotckiss et al., [@B20]) and even plants (Fox et al., [@B14]). Some EDCs have been linked to metabolic upsets and obesity (Decherf and Demeneix, [@B11]). Nevertheless, great debate continues on whether environmental levels of these and other EDCs are sufficiently biologically active to be of concern. However, the key examples of feminization of alligators and fish, and the decline and elimination of some species following contamination of lakes clearly indicates that environmental estrogens are affecting wildlife on a large scale (Guillette et al., [@B17]; Kidd et al., [@B23]; Hotckiss et al., [@B20]; Desforges et al., [@B12]). Perhaps most convincing is the ecosystems level study by Kidd et al. ([@B23]). They reported on experimental contamination of a large (34 ha) freshwater lake in the Experimental Lakes Area of Canada with the contraceptive ethinyl-estradiol (EE2). This direct addition of EE2 led to the feminization of male fathead minnows as indicated by the production of the egg yolk protein vitellogenin, intratesticular ovarian tissues, and near extinction of the species from the lake (Kidd et al., [@B23]). In wild roach in UK rivers, feminization resulting from pollution is a major problem that is linked to reduced fertility (Harris et al., [@B18]). Most studies on estrogenic EDCs in human wastewater effluents focus either on EE2 or the natural steroid estradiol 17-β (E2). This is surprising given that estrone (E1) is often the most abundant estrogen in the wastewater of some sewage treatment facilities (Williams et al., [@B51]; Johnson et al., [@B22]; Servos et al., [@B46]; Kumar et al., [@B27]), is found in farm sewage (Hutchins et al., [@B21]), soil (Ying and Kookana, [@B52]), and ocean sediments (Braga et al., [@B5]). Moreover, surprisingly little is known about the biological activity of E1 in aquatic vertebrates.

The investigation of steroidal estrogen behavior under ultraviolet (UV) radiation is important because when estrogens are released to the environment, they are exposed to solar radiation (UVA; λ = 320--400 nm, and UV-B; λ = 280--320 nm). Estrone, 17β-estradiol (E2), and 17α-ethinyl-estradiol (EE2) are candidates for UV photodegradation because they show maximum absorbance peaks in the UV spectrum (Coleman et al., [@B7]). Not reaching the earth's surface is the highly destructive UVC band (λ = 240--280 nm) that is filtered by the ozone layer. However, UVC lamps are used widely in STP treatment as an effective disinfection tool (Das, [@B10]). Combinations of UV and other remediation methods for the removal and degradation of E1 and other estrogens have also been reported (Coleman et al., [@B7]; Lin and Reinhard, [@B31]). Yet, the environmental fate of E1 and many other EDCs is still controversial. We (Atkinson et al., [@B3]) and others (Coleman et al., [@B7]; Liu and Liu, [@B32]) have reported on UV-mediated degradation of E1, and in some cases there appears to be some reduction in estrogenicity. On the other hand, some studies report no effect of UV on estrogen degradation (Cicek et al., [@B6]). In the course of our previous investigations (Atkinson et al., [@B3]) we found that UV-mediated degradation of E1 led to the formation of an unknown product that we identify and characterize here. We found that E1 can be rapidly photochemically converted to lumiestrone, a little known steroid that we also determined to be biologically active, rapidly produced upon natural sunlight exposure and present in urban sewage effluent.

Materials and Methods
=====================

Detection of estrogens
----------------------

One liter water grab samples of sewage effluents were collected in amber, air-tight bottles that were pre-rinsed with dichloromethane (ACS grade, Fisher Scientific) and baked overnight at 200°C. Water samples were stored in the dark at 4°C for up to 48 h. Immediately after sampling an isotope dilution was done by adding a C-13 labeled internal standards (Cambridge Isotope Laboratories, Andover, MA, USA) of E1, E2, and EE2 in acetonitrile. Extraction and analysis for steroidal estrogens followed previous strategies (Lee and Peart, [@B30]; Kuch and Ballschmiter, [@B26]) as validated in our laboratory (Atkinson et al., [@B3]). The samples were prefiltered through a 1.2-μm glass fiber filter and subsequently loaded onto a pre-treated 1 g ENVI-18 solid phase extraction (SPE) cartridge at a flow rate of 10 mL/min. The SPE was eluted with 5 mL acetone followed by 5 mL methanol. The extract was evaporated to dryness with nitrogen gas, and re-dissolved in 2 mL of high-pressure liquid chromatography (HPLC) water. A 10% pentafluorobenzoyl chloride derivative in toluene and 2 M potassium hydroxide was added to the sample and vortexed. After phase separation, the organic phase was extracted twice with 2.5 mL hexane and evaporated to 0.5 mL. The sample was subsequently passed through a sodium sulfate column, eluted with 7 mL of hexane, and evaporated to 200 μl for analysis on an Agilent 6890 gas chromatograph with a 5973 Mass Selective Detector in negative chemical ionization mode. One microliter was injected onto a Zebron ZB-5MS 30 m, 250 μm, 0.25 μm column with a flow rate of 1 mL/min of helium gas. The oven ramping commenced with 80°C held for 1 min, increasing at 24°C/min to 200°C and held for half a minute, 73°C/min until 245°C and held for 5 min, and then 1°C/min to 260°C. The mass spectrometer used methane as the reaction gas at a flow rate of 40 mL/min with the quad at 100°C and the source at 200°C. The ^12^C ions monitored were E1/lumiestrone 464, E2 466, and EE2 490 and the ^13^C ions were 466, 468, and 492, respectively. Both E1 and lumiestrone produced identical ion fragmentation patterns, and were quantified using identical protocols. Chromatographic data were collected and analyzed using Agilent MSD Chemstation Data Analysis Software.

The method detection limits (MDLs) were calculated using the protocol of the United States Environmental Protection Agency ([@B48]). The MDLs were obtained by injection of seven extracts from seven water samples (prepared from E1 and EE2 standards of 5 and 1 ng L^−1^, respectively, in 1 L double distilled water), where the SD for the mean concentration was multiplied by the one-tailed t statistic at a 95% confidence level. In addition, the linear responses of steroidal estrogens were determined from sample extracts of 0, 12.5, 25, 37.5 ng L^−1^ of E1 standards and from sample extracts of 0, 1, 2, 3, and 4 ng L^−1^ of EE2 standards. Blank samples of double distilled water and blank samples of hydromatrix were spiked with the ^13^C standards and taken through the extraction process. The MDL for E1 and EE2 in water were 1.8 and 0.3 ng L^−1^ respectively. No commercial standards are available for lumiestrone, but its ion fragmentation pattern and MDL are identical to E1.

Purification and characterization of lumiestrone
------------------------------------------------

Mid-day UV-B intensity along the Ottawa River (Ontario), typical of a partly cloudy day in summer was measured to be ∼110--140 mW cm^−2^ using the GOLDILUX radiometer/photometer GRP-1 (Model 70237) with an UV-BR probe GBP-1 (Model 0238). This measurement was used to design environmentally relevant UV exposures in controlled laboratory conditions. In another experiment, a solution of E1 (0.1 mM) dissolved in acetonitrile was irradiated with UVC in a photoreactor (model LZC-4V, Luzchem). Under various experimental conditions, the disappearance of E1 and the formation of its main photoproduct (lumiestrone) were followed by gas chromatography (GC); the solution was injected directly after irradiation on the column (Agilent HP-5MS, 0.25 mm × 30 m × 0.25 μm) of the GC/MS chromatogram (Agilent Technologies). The injector temperature was set at 250°C. The temperature program began at 50°C (for 10 min) and was increased up to 280°C (for 10 min) at a rate of 10°C/min. The temperature of the MS detector (Agilent, model 5973) was set at 150°C. In these conditions, by using 7 UVC lamps in the photoreactor, the almost complete conversion of E1 into lumiestrone was observed after 5 min irradiation. Lumiestrone was then purified by preparative high performance liquid chromatography. The purification was carried out on a preparative system from Shimadzu (model: LC-8A) equipped with a UV-detector (model: SPD-10A), the column employed was a preparative reverse-phase C-18 column (Supelco, discovery HS C-18, 250 mm × 21.2 mm × 5μm). Lumiestrone was obtained as a pure product after 17 min using an isocratic elution with 70% acetonitrile and 30% water and a flow of 10 mL/min. Lumiestrone was then characterized by nuclear magnetic resonance spectroscopy (NMR; Fielding et al., [@B13]). NMR spectra were recorded at 400 MHz for \[^1^H\] and 100 MHz for \[^13^C\] on a Bruker Avance 400 spectrometer. The carbon multiplicity was assessed by distortionless enhancement by polarization transfer (DEPT). The proton couplings were evidenced by ^1^H--^1^H COSY experiments. The heteronuclear chemical shift correlations were determined by HMQC and HMBC pulse sequences. The sample was prepared in methyl sulfoxide-d~6~ (99%) purchased from Aldrich.

*In vitro* reporter gene assays
-------------------------------

The zebrafish (zf) zfERα, zfERβ1, and zfERβ2 expression vectors, correspond to Topo-pcDNA3 expression vector (Invitrogen, San Diego, CA, USA), containing the coding regions of each receptor cDNA, as previously described (Menuet et al., [@B38]; Métivier et al., [@B40]). The *cyp19b--Luc* reporter gene consists of 500 bp of the proximal promoter region of zebrafish *cyp19b* gene, containing an estrogen response element (ERE), coupled to the firefly luciferase reporter gene (Le Page et al., [@B29], [@B28]). The ERE-tk-Luc reporter gene consists of a consensus ERE with a minimal thymidine kinase promoter driving firefly luciferase activity. The cytomegalovirus--β-galactosidase (CMV--βgal) was used as control internal plasmid. These vectors were described previously (Menuet et al., [@B38]; Métivier et al., [@B40]). The U251-MG (ER-negative glial cell line) and MCF-7 (ER-positive breast cancer cell line) cells were maintained at 37°C under a 5% CO~2~ atmosphere in Dulbecco's modified Eagle medium (DMEM; Sigma, St. Louis, MO, USA) supplemented with 10% fetal calf serum (FCS; Life Technologies, Carlsbad, CA, USA), 100 U/mL penicillin, 100 mg/mL streptomycin, and 25 mg/mL amphotericin (Sigma--Aldrich, St. Louis, MO, USA). U251-MG cells were plated in 24-well plates at a density of 0.2 × 10^5^ cells/mL. U251-MG were transfected with 25 ng of zfER expression vector, 150 ng of luciferase reporter construct and 25 ng of CMV--βgal control plasmid. MCF-7 were plated in 24-well plates at a density of 0.5 × 10^5^ cells/mL and transfected with 50 ng of ERE-TK-Luc and 25 ng of CMV--βgal per well. Transfection assays were performed with FuGENE 6 transfection reagent (Roche, Basel, Switzerland). After one night, medium was replaced with fresh DMEM-F12 containing 2% charcoal/dextran FCS with estrogenic test chemical or vehicle. The luciferase activities were assayed 48 h later using the luciferase assay system (Promega, Madison, WI, USA). We used β-galactosidase activity to normalize for transfection efficiency in all experiments. Each experiment was performed at least in triplicate.

*In vivo* treatments and gene expression analysis
-------------------------------------------------

All *in vivo* protocols were approved by the University of Ottawa Animal Care and Veterinary Services and were in accordance with the Canadian Council on Animal Care. Sexually regressed male goldfish were injected intraperitoneally with E2 (0.5 μg/g), E1 (0.5 μg/g), and lumiestrone (0.5 μg/g) or control vehicle (in charcoal-stripped peanut oil; 5 μL/g). Animals were anesthetized in MS222, and livers were harvested 24 h after injection, frozen on dry ice, and stored at −80°C until RNA extraction, cDNA synthesis and real-time multiplex PCR analysis for the three fish ERs or vitellogenin-1 by a SYBR-green-based simplex assay as validated in our laboratory (Marlatt et al., [@B34]) using the Mx4000^®^ Multiplex Quantitative PCR System (Stratagene, La Jolla, CA, USA). Analysis of the ∼10 K carp-goldfish microarray data including statistical analysis followed our established and well-validated strategies (Gracey et al., [@B16]; Martyniuk et al., [@B36]; Williams et al., [@B50]). Pooled control liver cDNA was hybridized against four independent samples from lumiestrone-treated males. Hybridizations were performed using the protocol supplied by Genisphere. Microarrays were scanned at full speed 10 μm resolution using the ScanArray 5000 XL system (Packard Biosciences/PerkinElmer) using both red and blue lasers. Images were obtained with ScanArray Express software using automatic calibration sensitivity varying PMT gain (PMT starting at 65% for Cy5 and 70% for Cy3) with fixed laser power at 80% and the target intensity set for 90%. Microarray images were analyzed using QuantArray (Packard Biosciences/Perkin Elmer) and raw signal intensity values were obtained for duplicate spots of genes. We used Alien Spot Report Genes 1--10 (Stratagene, La Jolla, CA, USA) to normalize microarray data and the Significance Analysis of Microarray method (Tusher et al., [@B47]; SAM) for microarray analysis. Candidate genes identified as being differentially regulated (*q*-value \< 5) were further analyzed using the GOSSIP package in Blast2GO (Conesa et al., [@B8]) for gene ontology categorizations. The microarray data are accessible via the Gene Ontology Omnibus at NCBI (accession no. GSE12252).

Results and Discussion
======================

When E1 was placed in either distilled water or river water and exposed to an environmentally relevant level of UV-B (135 mW cm^−2^), a photodegradation product of the same molecular weight as E1 was obtained. This shows that the process is direct and not a photosensitized reaction. The appearance of this unknown photoproduct confirms our previous observations (Atkinson et al., [@B3]). This photoproduct was isolated by preparative HPLC and characterized by NMR as the 13α-epimer form of E1, lumiestrone \[Estra-1,3,5(10)-trien-17-one, 3-hydroxy-, (13α)- (9CI)\]. To determine the process of formation of lumiestrone, a series of fundamental photochemical experiments were realized in organic solvent. As observed, brief irradiation of E1 with UV-B under aerobic conditions in acetonitrile leads to the almost complete conversion of E1 into lumiestrone (Figure [1](#F1){ref-type="fig"}). Longer irradiations induce the complete disappearance of E1, and eventually lumiestrone, indicating that the photoproduct is more robust than the parent compound (Figure [1](#F1){ref-type="fig"}).

![**Conversion of estrone into lumiestrone in acetonitrile following exposure to UV-B radiation, followed by gas chromatography**. Irradiation times were **(A)** 0 min, **(B)** 5 min, **(C)** 15 min, **(D)** 30 min.](fendo-02-00083-g001){#F1}

Electron paramagnetic resonance spectroscopy using gaseous nitric oxide $\text{NO}^{\bullet}$ as the spin trap coupled to irradiation of an E1 solution yields a nitroxide radical signal (*a*~N~ = 7.3 G; Figure [A1](#FA1){ref-type="fig"} in Appendix) very close to the one reported for cyclopentanone (Maruthamuthu and Scaiano, [@B37]). This proves that 13α-epimerization of E1 is via the Norrish type I photocleavage of a cyclic ketone as depicted in Figure [2](#F2){ref-type="fig"}.

![**Proposed mechanism for the phototransformation of estrone into lumiestrone**.](fendo-02-00083-g002){#F2}

Nanosecond laser flash photolysis experiments were also undertaken. Lumiestrone was produced and no traces of bi-radical formation were observed in the nanosecond time scale, indicating a rapid conversion (\<20 ns) of E1 to lumiestrone. UVA was also used in order to photodamage E1 but no phototransformations were observed since E1 does not absorb in this region. Significantly, UV-B irradiation of E1 in water (with \<1% ethanol) also leads to the formation of a single product, lumiestrone (Figure [A2](#FA2){ref-type="fig"} in Appendix). Untreated sewage water obtained from the Mercato san Severino sewage treatment plant (Salerno, Italy) was filtered to remove grit. Estrone was dissolved in this sewage water and irradiated by natural sunlight in July in Napoli, Italy. This is environmentally relevant because effluents can be exposed to sunlight in holding ponds or as they are released to the receiving environment. Degradation is slower than under laboratory conditions, probably related to reduced penetration of UV-B in a dark sewage sample relative to clear water, but lumiestrone is still the only photodegradation product (Figure [A3](#FA3){ref-type="fig"} in Appendix). Lumiestrone could be detected by HPLC within 60 min. Additionally, sewage water spiked with E1 (10 μM) was exposed to UV-B irradiation and lumiestrone could be detected with HPLC within 1 min (Figure [A4](#FA4){ref-type="fig"} in Appendix). After 10 min E1 was degraded but lumiestrone persisted.

Is lumiestrone biologically active? A common screening strategy for assessing estrogenicity of environmental chemicals involves treatment of male fish and quantification of estrogen-dependent gene expression in the liver. The promoter of estrogen receptor alpha (ERα) genes of teleost fish contain a functional, sensitive, and characterized ERE. Thus, the auto-regulation response of ERα serves as a sensitive physiologically relevant biomarker for estrogenicity (Martyniuk et al., [@B36], [@B35]; Marlatt et al., [@B34]). Multiplex real-time RT-PCR determination of all three known nuclear ERs in goldfish revealed that E1 and E2 stimulated 80- to 90-fold increases in hepatic ERα (*p* \< 0.01; Figure [A5](#FA5){ref-type="fig"} in Appendix), but not the other ER receptor subtypes. In marked contrast, lumiestrone did not affect expression of any of these genes (*p* \> 0.05), suggesting that it is not estrogenic. Therefore we pursued two other approaches to test if 13α-epimerization of E1 indeed leads to complete loss of biological activity. All three compounds were screened through established highly sensitive reporter gene assays *in vitro*. Transfection of ER-negative U251-MG human glial cells with zebrafish *ERα, ERβ1, ERβ2*, and the c*yp19β-Luc* reporter revealed that E1 and E2 activated all three receptors. At high dose (at final concentration 100-fold more than E2 or E1), lumiestrone activated both zfERα and zfERβ2, but not zfERβ1. Lumiestrone showed relatively higher estrogenic potency with zfERβ2 than zfERα, suggesting that it may act through an ERβ-selectivity (Figures [3](#F3){ref-type="fig"}A--C). This modest estrogenicity was confirmed in ERα and ERβ-positive human breast cancer MCF-7 cells transfected with the ERE-tk-Luc reporter. In both cell-based assays, even at high concentrations (1000 nM), lumiestrone did not show full estrogenic activity but 20--70% of the maximal activity induced by E2 (Figure [3](#F3){ref-type="fig"}D). This level of estrogenicity for lumiestrone is similar to or greater than numerous other chemicals with known endocrine disrupting activities (Andersen et al., [@B2]).

![**Screening transcriptional activities of estradiol (E2), estrone (E1) and lumiestrone (LE) using estrogen receptor-dependent reporter gene assays *in vitro***. ER-negative U251-MG glial cells were transfected with zebrafish *ERα* (**(A)**), *ERβ1* **(B)**, and *ERβ2* **(C)** and exposed to estrogens or the dimethyl sulfoxide (DMSO) control. In **(D)** ERα and ERβ-positive human breast cancer MCF-7 cells were used. Data are presented as mean + SEM of luciferase activity relative to β-gal (*n* = 3). Data were tested for normality and homoscedasticity, and were transformed when appropriate prior to analysis by one-way ANOVA (treatment; *p* \< 0.001) followed by Tukey's *post hoc* test (S-Plus, v8.0). ^a,b,c,d^Means labeled with different superscripts are significantly different (*p* \< 0.05).](fendo-02-00083-g003){#F3}

These *in vitro* results indicate that lumiestrone activates both fish and human ER. As of yet, there are no known direct or indirect gene targets of the ERβ2 in fish, therefore, we adopted a microarray strategy to determine if indeed lumiestrone possess biological activity *in vivo*. Microarray screening of livers from control and lumiestrone-injected male goldfish revealed that a single injection of the major E1 photoproduct is biologically active. Statistical analysis indicated that 20 and 69 mRNAs were up- or down-regulated, respectively. Of these 89 mRNAs, 22 were identified using Blast2GO (Table [A1](#TA1){ref-type="table"} in Appendix; *q* \< 5 and fold change cutoff \>1.4), while the remaining 67 were expressed sequence tags that were not identifiable and were excluded from further analysis. As determined by standard gene ontology classifications, eight biological processes were affected by lumiestrone (Table [A1](#TA1){ref-type="table"} in Appendix). These categorizations were statistically significant and include three to six identified genes (Table [A1](#TA1){ref-type="table"} in Appendix) related to signal transduction \[6\], cellular protein metabolic processes \[5\], transport \[4\], macromolecule biosynthetic processes \[3\], cellular biosynthetic processes \[3\], cellular component assembly \[3\], organelle organization and biogenesis \[3\], and DNA-dependent regulation of transcription \[3\]. Based on the genes we could assign functions, the effects of lumiestrone appear to be that of metabolic upset, perhaps linked to changes in the various biosynthetic processes, and/or detoxification. For example, increased expression of glutathione *S*-transferase rho may be expected to contribute to increased detoxification, while a decrease in cytochrome oxidase subunit 1 may be indicative of reduced oxidative metabolism. At least three genes affected by lumiestrone are indicative of endocrine disruption. Lumiestrone decreased expression of a high-mobility box protein, which is a coactivator that regulates ER binding to the ERE (Das et al., [@B9]). Both somatostatin-1b and the type 2 somatostatin receptor (SSTR2) were upregulated by lumiestrone, indicating an effect on a growth regulatory system. It is noteworthy that the human SSTR2 has functional EREs (Kimura et al., [@B24]). Somatostatins and their receptors in the liver control fibrogenesis in mammals (Reynaert et al., [@B45]) and insulin-like growth factor production in fish (Very et al., [@B49]). Importantly, only 25% (22/89) of the differentially expressed genes could be identified, so other biological pathways and effects of lumiestrone could be expected but will require de-orphanization of these other expressed sequence tags. Overall, both the *in vitro* reporter gene assays and the microarray data indicate that lumiestrone is a biologically active estrogenic derivative of E1.

To the best of our knowledge the hepatic transcriptional profile for E1 has not been determined in any fish. Direct comparison of the microarray data obtained for lumiestrone to E1 is therefore not possible at this time. Nevertheless, the hepatic transcriptional responses to lumiestrone are clearly different from previously published data for both steroidal and non-steroidal estrogenic EDCs in two related *Cyprinidae* species, the common carp (Moens et al., [@B41]) and zebrafish (Martyniuk et al., [@B35]). The only similarities we noted were the effects of these estrogenic chemicals on glutamine synthetase (GS) and apolipoprotein, both of which are also linked to metabolic effects. Glutamine synthetase-1 is upregulated in carp liver after various estrogenic exposures (Moens et al., [@B41]). Here we observed that lumiestrone upregulated glutamine synthase-2. Glutamine synthetase catalyzes the ATP-dependent formation of glutamine from ammonia and glutamate, and is important for detoxification of ammonia (Murray et al., [@B43]). Moreover, GS may be an early marker for hepatocellular carcinoma in humans (Long et al., [@B33]). In our previous work, the contraceptive EE2 decreased apolipoprotein A1 mRNA in male zebrafish liver (Martyniuk et al., [@B35]), while here we observed a decrease in hepatic apolipoprotein Eb mRNA after lumiestrone treatment in male goldfish. Apolipoproteins are important for lipid transport, lipoprotein metabolic process and are implication in numerous conditions, for example, abnormalities of blood lipids and in cardiovascular disease.

Analysis of samples from a wastewater treatment plant (Ottawa, Canada) with secondary treatment indicates that lumiestrone is a candidate environmental contaminant of concern. We detected E1 in 100%, E2 in 55%, and both EE2 and lumiestrone in 10% of samples of raw sewage (*n* = 10) and final effluent (*n* = 10). Mean (±SD; with range) concentrations in sewage for E1, E2, EE2, and lumiestrone were respectively, 103 (±21; 11--370), 18 (±21; 0--67), 0.14 (±0.4; 0--1.3), and 0.05 (±0.14; 0--0.46) ng/L. Mean (±SD; with range) concentrations in final effluent for E1, E2, EE2, and lumiestrone were respectively, 49 (±115; 35--103), 8 (±10; 0--27), 0.06 (±0.18; 0--0.6), and 0.03 (±0.1; 0--0.34) ng/L. We have not determined at which stage in sewage handling and treatment that lumiestrone would be produced. However, the frequency of detection of lumiestrone in the low ng/L range is similar to EE2 in our study and also comparable to dozens pharmaceuticals of concern already recognized as wastewater contaminants (Kolpin et al., [@B25]; Metcalfe et al., [@B39]). Critically missing are more detailed analyses of the steps in wastewater processing when E1 could be converted to lumiestrone, more completely degraded or sequestered by sediments.

Lumiestrone is photochemically produced from E1 and therefore is not directly of biological origin. It is plausible that lumiestrone can be formed at any stage where sewage would be exposed to sunlight. This suggestion is based on the short time and low level of UV energy required to generate lumiestrone under experimental conditions in several aqueous media, and in sewage effluent exposed to natural sunlight. This could happen during transport through sewage systems to the water treatment plant, during aeration procedures, or in settling ponds prior to and after the release to the aquatic receiving environment. Another possible process that may produce lumiestrone in wastewater is during UV treatment of sewage, which is beginning to be commonplace in some countries (Das, [@B10]; Yoon et al., [@B53]; Hébert et al., [@B19]; Bilotta and Daniel, [@B4]; Friedler and Gilboa, [@B15]).

In conclusion, we demonstrate UV-B-mediated production of lumiestrone, a novel photoproduct derived from an environmentally relevant estrogenic steroid. While sewage treatment has improved considerably, there are still no widespread methods for removing environmental estrogens that pose a risk to the health of vertebrates (Guillette et al., [@B17]; Kidd et al., [@B23]; Hotckiss et al., [@B20]; Ottinger et al., [@B44]; Desforges et al., [@B12]; Mouritsen et al., [@B42]; Decherf and Demeneix, [@B11]; Harris et al., [@B18]). Most treatment facilities currently in operation are not designed to remove natural or synthetic estrogens or the multitude of biologically active pharmaceuticals or chemicals found in personal health care products. That one pollutant, E1, itself abundant and biologically active, can be transformed into an epimer with significantly different biological activity suggests that other phototransformations involving at least some of the hundreds of other EDCs found in sewage and released into aquatic ecosystems over the world may be possible. This will not only be an added problem for developed nations where there is the possibility for secondary and tertiary treatments including artificial UV treatments. In rural villages or megacities in developing nations, it may be worse where sewage from farms or urban and suburban regions is released without any treatment. Given that sewage lagoons in swine, poultry, dairy, and beef cattle farms all contain very high amounts of E1, and numerous other estrogens in ng/L to μg/L range (Hutchins et al., [@B21]), production of lumiestrone and other novel chemicals is likely. Estrone can also be found in ocean sediments (Braga et al., [@B5]) and persistence of estrogens from sewage biosolid applications to soil indicate that E1 is also in terrestrial environments (Ying and Kookana, [@B52]). We showed that natural levels of solar radiation can catalyze the formation of the new endocrine-active pollutant lumiestrone. As we have done for EE2 (Al-Ansari et al., [@B1]), it will be important in future studies to determine uptake and bioconcentration potentials to fully understand the impact of lumiestrone on aquatic vertebrates.
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Materials and Methods and Results for the quenching of the transient bi-radical by nitric oxide are presented in Figure [A1](#FA1){ref-type="fig"}. Formation of lumiestrone under several conditions is shown in Figures [A2](#FA2){ref-type="fig"}--[A4](#FA4){ref-type="fig"}. The effects of E1, E2 and lumiestrone on hepatic estrogen receptor expression are shown in Figure [A5](#FA5){ref-type="fig"}. The candidate genes identified using cDNA microarrays as being differentially regulated by lumiestrone are presented in Table [A1](#TA1){ref-type="table"}.

![**Quenching of the transient bi-radical by nitric oxide**. Electron paramagnetic resonance spectrum obtained upon irradiation of a 5 × 10^−4^-M solution of estrone in acetonitrile under UV-B. A solution of estrone (0.5 mM) dissolved in acetonitrile was degassed with nitrogen in order to avoid *in situ* formation of nitric dioxide. The solution was then saturated with a mixture containing 5% nitric oxide in nitrogen, and was allowed to flow through a conventional Electron paramagnetic resonance spectroscopy (EPR) flat cell (Suprasil) at a rate of 1 mL/min. The solution saturated with nitric oxide was continuously irradiated in the EPR cavity by the means of a Xenon illuminator (model LUZ-XE, Luzchem). The EPR spectra were recorded at room temperature on a FA-100 JEOL EPR spectrometer. The experimental setting was as followed: microwave power 1 mW, modulation width 0.1 mT, sweep time 1 min, time constant 0.03 s.](fendo-02-00083-a001){#FA1}

![**Conversion of estrone into lumiestrone in water (ethanol \<1%) following exposure to UV-B radiation followed by gas chromatography**. Irradiation times were **(A)** 0 min, **(B)** 15 min, **(C)** 45 min.](fendo-02-00083-a002){#FA2}

![**High-pressure liquid chromatography chromatograms of estrone solutions (10 μM) irradiated by sunlight at different times**. **(A)** *t* = 0, **(B)** *t* = 15, **(C)** *t* = 60, **(D)** *t* = 120, and **(E)** *t* = 180 min. In order to simulate environmental conditions estrone was dissolved in untreated sewage water and irradiated by sunlight in Napoli (Italy) in July 2007. HPLC analysis was performed under isocratic conditions (H~2~O/CH~3~CN 1:1) on an Agilent 1100 Binary HPLC pumps system equipped with a UV-detector. The column used was a reverse-phase Gemini 5 μ C-18 (250 × 4.60 mm). The detector was set at 220 nm.](fendo-02-00083-a003){#FA3}

![**High-pressure liquid chromatography chromatograms of estrone solutions (10 μM) in untreated sewage water) irradiated by UV-B (135 μW cm^−2^; Helios Italquarz) for different times**. **(A)** *t* = 0, **(B)** *t* = 1 min, **(C)** *t* = 4 min, and **(D)** *t* = 10 min. HPLC analysis under isocratic conditions (H~2~O/CH~3~CN 1:1) was performed on an Agilent 1100 Binary HPLC pumps system equipped with a UV-detector. The column used was a reverse-phase Gemini 5 μ C-18 (250 × 4.60 mm). The detector was set at 220 nm.](fendo-02-00083-a004){#FA4}

![**The effect of i.p. injections (0.5 μg/g) of estradiol (E2), estrone (E1), lumiestrone (LE), and control (charcoal-stripped peanut oil; 5 μL/g) on expression of liver estrogen receptor (ER)α in sexually in sexually inactive male goldfish using multiplex real-time PCR (8) after 24 h**. Data (*n* = 6) are expressed as the mean (*n* = 6; ±SEM) fold change relative to the ERβ/β-actin ratios of the controls. Data were tested for normality and homoscedasity, and were transformed when appropriate prior to analysis by one-way ANOVA (treatment; *p* \< 0.001) followed by Tukey's *post hoc* test (S-Plus, v8.0). ^a,b^Means labeled with different superscripts are significantly different (*p* \< 0.05). Note that ER β1 and ER β2 mRNAs were also measured in this PCR (not shown) but were not affected by treatment (*p* \> 0.05). A subset (*n* = 3) of samples was screened by SYBR-Green-based PCR for vitellogenin-1 (VTG-1). VTGs are abundant phosphoproteins normally produced in the female liver that are released into circulation and accumulate in developing oocytes to provide nourishment for developing fish larvae. The gene is largely silent and undetectable in males unless they are exposed to estrogenic chemicals. No VTG-1 transcripts were amplified from control or LE-treated samples whereas it was detectable in all three of the samples from the E2 and E1-treatment groups. These data followed the general pattern for ERα and the average VTG-1/β-actin ratios for control, E2, E1, and LE were respectively 0 (not-detectable), 4.2, 5.9, and 0 (not-detectable).](fendo-02-00083-a005){#FA5}

###### 

**Multilevel gene ontology classifications of transcripts expressed in male goldfish liver identified by version 1.1 of the goldfish-carp cDNA microarray to be affected by lumiestrone**.

  Gene_ID   Gene Blast X hit                                       Biological process                                                                                                                                                                                                                              Molecular function                                                                                                                                                                                         Cellular component                                                                    Direction   *q*-Value   Fold Change
  --------- ------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ----------- ----------- -------------
  15b05     COP9 constitutive photomorphogenic homolog subunit 4   --                                                                                                                                                                                                                                              Protein binding                                                                                                                                                                                            Cytoplasm, signalosome                                                                Down        3.65        1.635
  25m12     TPA_exp: glutamine synthetase                          Glutamine biosynthetic process, peptidoglycan biosynthetic process                                                                                                                                                                              Glutamate--ammonia ligase activity                                                                                                                                                                         --                                                                                    Up          3.99        1.553
  27l09     High-mobility group box 1                              Regulation of transcription, DNA-dependent                                                                                                                                                                                                      DNA binding                                                                                                                                                                                                Chromatin, nucleus                                                                    Down        3.65        1.407
  28c20     Glutathione *S*-transferase rho                        --                                                                                                                                                                                                                                              Transferase activity                                                                                                                                                                                       --                                                                                    Up          0           1.856
  30g10     Integral membrane protein 2B                           Induction of apoptosis                                                                                                                                                                                                                          Protein binding, ATP binding                                                                                                                                                                               Membrane fraction, integral to membrane, mitochondrion                                Down        3.65        1.430
  30h23     Glucose-6-phosphatase                                  --                                                                                                                                                                                                                                              Hydrolase activity                                                                                                                                                                                         Membrane                                                                              Up          0           1.843
  30h24     FK506 binding protein 5                                Protein folding                                                                                                                                                                                                                                 Peptidyl-prolyl cis--trans isomerase activity                                                                                                                                                              --                                                                                    Up          0           1.811
  39c13     Predicted: similar to ribosomal protein S2             Translation, ribosome biogenesis and assembly                                                                                                                                                                                                   RNA binding, structural constituent of ribosome                                                                                                                                                            Cytosolic small ribosomal subunit                                                     Up          0           1.540
  40e24     Ribosomal protein S15a, isoform CRA_b                  Translation, ribosome biogenesis and assembly                                                                                                                                                                                                   RNA binding, structural constituent of ribosome, protein binding                                                                                                                                           Cytosolic small ribosomal subunit                                                     Up          0           1.711
  42f19     Cytochrome oxidase subunit I                           Mitochondrial electron transport (cytochrome-c to oxygen), aerobic respiration, proton transport                                                                                                                                                Cytochrome-c oxidase activity, iron ion binding, copper ion binding, heme binding                                                                                                                          Mitochondrial respiratory chain, respiratory chain complex IV, integral to membrane   Down        4.88        1.426
  42m12     Beta-tubulin                                           Microtubule-based movement, spindle assembly, protein polymerization                                                                                                                                                                            GTPase activity, GTP binding, structural constituent of cytoskeleton                                                                                                                                       Cytoplasm, tubulin complex                                                            Down        3.65        1.465
  42n16     Apolipoprotein Eb                                      Lipid transport, negative regulation of signal transduction, lipoprotein metabolic process                                                                                                                                                      Lipid binding                                                                                                                                                                                              Extracellular region, signal recognition particle (endoplasmic reticulum targeting)   Down        3.65        1.479
  43k04     RTN4-M                                                 --                                                                                                                                                                                                                                              --                                                                                                                                                                                                         Endoplasmic reticulum                                                                 Up          0           1.565
  43n02     Somatostatin-1B precursor                              Signal transduction                                                                                                                                                                                                                             Hormone activity                                                                                                                                                                                           Extracellular region                                                                  Up          3.23        1.481
  43p01     Somatostatin receptor type 2                           Neuropeptide signaling pathway, synaptic transmission, G-protein signaling (adenylate cyclase inhibiting pathway), response to nutrient, digestion, peristalsis, negative regulation of cell proliferation, regulation of muscle contraction    Somatostatin receptor activity, PDZ domain binding, melanin-concentrating hormone activity, purinergic nucleotide receptor activity (G-protein coupled), neuropeptide Y receptor activity                  Membrane fraction, integral to plasma membrane                                        Up          0           1.575
  54m19     Hypothetical protein LOC553288                         --                                                                                                                                                                                                                                              UDP-glucose:glycoprotein glucosyltransferase activity                                                                                                                                                      --                                                                                    Down        3.65        1.451
  55k21     Hypothetical protein LOC564707                         Transcription initiation from RNA polymerase II promoter, androgen receptor signaling pathway, positive regulation of transcription from RNA polymerase II promoter                                                                             Thyroid hormone receptor binding, receptor activity, RNA polymerase II transcription mediator activity, ligand-dependent nuclear receptor transcription coactivator activity, vitamin D receptor binding   Mediator complex, transcription factor complex                                        Down        3.65        1.513
  59d21     Echinoderm microtubule associated protein like 2       Regulation of transcription, DNA-dependent                                                                                                                                                                                                      --                                                                                                                                                                                                         Microtubule                                                                           Down        3.65        1.467
  59d24     Transposase                                            Transposition, DNA-mediated                                                                                                                                                                                                                     DNA binding, transposase activity                                                                                                                                                                          --                                                                                    Down        0           1.547
  59k22     RNA binding motif protein, X-linked                    --                                                                                                                                                                                                                                              Nucleotide binding, nucleic acid binding                                                                                                                                                                   Ribonucleoprotein complex                                                             Down        3.65        1.420
  61g21     Hypothetical protein LOC563359                         Protein complex assembly, intracellular protein transport, signal transduction, vesicle-mediated transport, antigen processing, and presentation (exogenous lipid antigen via MHC class Ib), positive regulation of NK T cell differentiation   Receptor activity, protein binding, protein transporter activity                                                                                                                                           Golgi apparatus, integral to membrane, membrane coat                                  Down        4.88        1.399

*The microarray data have been submitted to GEO (GSE11252)*.
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